Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife

This article was originally published in The Tan Sheet

Executive Summary

Supplement marketer will increase product/sales training events, enhance market-specific instructional materials and rejuvenate reward and recognition programs to address sales shortfalls in Japan and South Korea, Herbalife announces Feb. 22 during analyst call on fourth quarter and year-end results. Disappointing sales in those countries, coupled with unfavorable currency fluctuations, resulted in 14% decline in fourth quarter retail sales to $423.3 mil. and flat sales for 2000 at $1.76 bil. Firm says it is working successfully with large number of suppliers to increase operating flexibility; Herbalife was sued by Global Health Sciences in December for allegedly reneging on oral agreement by forming new supplier contracts with alternative manufacturers (1"The Tan Sheet" Jan. 22, p. 13)

You may also be interested in...



Global Health Sciences Future Product Purchases "Unlikely" - Herbalife

Herbalife International said it is working to ensure a smooth transition to new suppliers following the deterioration of its relationship with, and subsequent lawsuit filed by, nutritional supplement manufacturer Global Health Sciences.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092226

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel